Скачать или смотреть BioStock Investor Pitch | ExpreS2ion Biotechnologies | March 2023

CEO Bent U. Frandsen presents ExpreS2ion Biotechnologies in connection with the rights issue 2023.

The invitation to persons concerned to subscribe for units in ExpreS2ion Biotechnologies will only take place through the prospectus published on 27 March 2023. The prospectus has been approved and registered by the Financial Supervisory Authority and published on https://expres2ionbio.com/.

Videons innehåll är sponsrat av det aktuella bolaget som förekommer i videon. BioStock tillhandahåller inte investeringsrådgivning, förmedlar inga investeringsorder och tar inget ansvar för agerande och/eller eventuell förlust eller skada av något slag som grundar sig på användandet av innehåll som publicerats på BioStock.se. Varje investeringsbeslut fattas istället självständigt av den enskilde investeraren.

0:00 Introduction
0:19 Investment highlights
2:08 Business model
2:58 Technology platforms
4:00 Vaccine pipeline
5:48 Covid-19 vaccine
7:06 Partnership with Bavarian Nordic
8:07 Breast cancer
8:28 Current breast cancer treatments
9:05 Data so far
9:25 Preclinical proof-of-concept
10:04 Advancing towards key catalysts
11:35 Q&A

Subscribe and follow BioStock on:
YouTube https://bit.ly/Biostock
LinkedIn:   / biostock  
Facebook:   / biostock.se  
Twitter:   / biostock_swe  

https://www.biostock.se/
#BioStock #LifeScience #ExpreS2ionBiotechnologies

About BioStock
BioStock is Scandinavia's leading digital news and analysis service with an exclusive focus on the Life Science sector. Our primary editorial office is found at Medicon Village in Lund, one of Sweden's foremost innovation clusters for life science companies, while our second editorial office is located in central Stockholm with proximity to both life science companies and financial players. We have TV studios on both sites.